Fresenius Medical Care AG
FMCQF
$58.68
$1.442.52%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.92B | 20.91B | 20.86B | 21.00B | 21.12B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.92B | 20.91B | 20.86B | 21.00B | 21.12B |
| Cost of Revenue | 15.80B | 15.77B | 15.62B | 15.68B | 15.76B |
| Gross Profit | 5.12B | 5.14B | 5.24B | 5.32B | 5.37B |
| SG&A Expenses | 3.35B | 3.40B | 3.41B | 3.45B | 3.46B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -97.49M | -118.23M | -149.81M | -79.96M | -45.68M |
| Total Operating Expenses | 19.25B | 19.25B | 19.10B | 19.28B | 19.41B |
| Operating Income | 1.67B | 1.67B | 1.76B | 1.72B | 1.71B |
| Income Before Tax | 1.24B | 1.15B | 1.32B | 1.16B | 1.10B |
| Income Tax Expenses | 363.95M | 342.60M | 370.66M | 338.81M | 320.56M |
| Earnings from Continuing Operations | 874.47 | 803.38 | 953.71 | 823.55 | 776.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -208.52M | -219.53M | -238.87M | -251.09M | -253.01M |
| Net Income | 665.95M | 583.85M | 714.85M | 572.46M | 523.94M |
| EBIT | 1.67B | 1.67B | 1.76B | 1.72B | 1.71B |
| EBITDA | 2.96B | 2.97B | 3.08B | 3.06B | 3.18B |
| EPS Basic | 2.27 | 1.99 | 2.44 | 1.95 | 1.79 |
| Normalized Basic EPS | 2.41 | 2.28 | 2.36 | 2.21 | 2.20 |
| EPS Diluted | 2.26 | 1.98 | 2.43 | 1.95 | 1.78 |
| Normalized Diluted EPS | 2.41 | 2.28 | 2.36 | 2.21 | 2.20 |
| Average Basic Shares Outstanding | 1.17B | 1.17B | 1.17B | 1.17B | 1.17B |
| Average Diluted Shares Outstanding | 1.17B | 1.17B | 1.17B | 1.17B | 1.17B |
| Dividend Per Share | 1.54 | 1.54 | 1.28 | 1.28 | 1.28 |
| Payout Ratio | 56.43% | 64.37% | 52.57% | 65.65% | 68.27% |